Concord Drugs Ltd Share Price

21.85

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 23-May-2019 - -
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve the audited financial results for the quarter and year ended 31-03-2019
Board Meeting - 24-Jan-2019 - -
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve Un-audited financial results for the quarter ended 31.12.2018 Closure of Trading Window for the un-audited financial results for the quarter ended 31.12.2018 Quarterly Results (Revised) (As per BSE Bulletin dated on 13/02/2019) Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Concord Drugs Limited scheduled to be held Wednesday, 13.02.2019 has been deferred to Thursday, 14.02.2019 at 5:00 p.m. at the registered office of the company for consideration of un-audited results for the quarter ended 31.12.2018 and any other matter with the permission of the chair (As Per BSE Announcement Dated 13.02.2019) Results-financial results for quater ended 31-12-2018 (As Per BSE Announcement Dated on 14/02/2019)
Board Meeting - 05-Nov-2018 - -
CONCORD DRUGS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.09.2018
Board Meeting - 02-Aug-2018 - -
Unaudited Financial Results CONCORD DRUGS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve 1. Un-audited financial results for the quarter ended 30.06.2018 2. To fix the day, date, time and venue of the ensuing Annual General Meeting of the Company. 3. Any other business with the permission of the Chair. Outcome of Board meeting held on 14.08.2018 (As Per BSE Announcement Dated on 14.08.2018) Concord Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2018 to September 29, 2018 (both days inclusive) for the purpose of 23rd Annual General Meeting (AGM) of the Company to be held on September 29, 2018. (As Per BSE Announcement Dated on 17.08.2018)